Company news

Share this article:
Eli Lilly announced a definitive agreement to acquire SGX Pharmaceuticals, a biotech specializing in oncology products, for $64 million, in an all-cash transaction.

Sudler & Hennessey announced the launch of 98.6°, a new patient health division. Jeanne Cloppse, managing director, will oversee the team. Areas of focus include disease state communications, treatment option and decisions, healthcare systems and the importance of compliance.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Avastin pockets another Priority Review label

It's the second for this cancer drug in two weeks.

Court invalidates some healthcare subsidies

The lawsuit has been wending its way through the courts for a while, and, although it is being deliberated in several other venues, the decision is part of a legal dispute that puts patients in the 36 states offering federal exchanges in limbo.

FDA generic division overhaul kicks in

The Food and Drug Administration has been intent on elevating and reorganizing its office of Generic Drugs since 2012.